Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 294 entries
Sorted by: Best Match Show Resources per page
Sputum Gene Expression of IL-13 Receptor α2 Chain Correlates with Airflow Obstruction and Helper T-Cell Type 2 Inflammation in Asthma.

Annals of the American Thoracic Society

Nezgovorova V, Liu Q, Hu B, Villalobos JL, Yan X, Niu N, Holm C, Grant NP, Marone S, Ravage-Mass L, Lee CG, Elias JA, Cohn L, Chupp GL.
PMID: 27027964
Ann Am Thorac Soc. 2016 Mar;13:S96-7. doi: 10.1513/AnnalsATS.201509-611MG.

BACKGROUND: BRP-39/YKL-40 is a chitinase-like protein that plays a critical role in IL-13-induced inflammation. It correlates positively with asthma severity and airway remodeling ( 1 ) via binding to IL-13 receptor α2 chain (IL-13Rα2). Because the relationship of IL-13Rα2...

Cite
Nezgovorova V, Liu Q, Hu B, et al. Sputum Gene Expression of IL-13 Receptor α2 Chain Correlates with Airflow Obstruction and Helper T-Cell Type 2 Inflammation in Asthma. Ann Am Thorac Soc. 2016;13:S96-7doi: 10.1513/AnnalsATS.201509-611MG.
Nezgovorova, V., Liu, Q., Hu, B., Villalobos, J. L., Yan, X., Niu, N., Holm, C., Grant, N. P., Marone, S., Ravage-Mass, L., Lee, C. G., Elias, J. A., Cohn, L., & Chupp, G. L. (2016). Sputum Gene Expression of IL-13 Receptor α2 Chain Correlates with Airflow Obstruction and Helper T-Cell Type 2 Inflammation in Asthma. Annals of the American Thoracic Society, 13S96-7. https://doi.org/10.1513/AnnalsATS.201509-611MG
Nezgovorova, Vera, et al. "Sputum Gene Expression of IL-13 Receptor α2 Chain Correlates with Airflow Obstruction and Helper T-Cell Type 2 Inflammation in Asthma." Annals of the American Thoracic Society vol. 13 (2016): S96-7. doi: https://doi.org/10.1513/AnnalsATS.201509-611MG
Nezgovorova V, Liu Q, Hu B, Villalobos JL, Yan X, Niu N, Holm C, Grant NP, Marone S, Ravage-Mass L, Lee CG, Elias JA, Cohn L, Chupp GL. Sputum Gene Expression of IL-13 Receptor α2 Chain Correlates with Airflow Obstruction and Helper T-Cell Type 2 Inflammation in Asthma. Ann Am Thorac Soc. 2016 Mar;13:S96-7. doi: 10.1513/AnnalsATS.201509-611MG. PMID: 27027964; PMCID: PMC5015742.
Copy Download .nbib Format: NLM
Substance use disorders in military veterans: prevalence and treatment challenges.

Substance abuse and rehabilitation

Teeters JB, Lancaster CL, Brown DG, Back SE.
PMID: 28919834
Subst Abuse Rehabil. 2017 Aug 30;8:69-77. doi: 10.2147/SAR.S116720. eCollection 2017.

Substance use disorders (SUDs) are a significant problem among our nation's military veterans. In the following overview, we provide information on the prevalence of SUDs among military veterans, clinical characteristics of SUDs, options for screening and evidence-based treatment, as...

Cite
Teeters JB, Lancaster CL, Brown DG, et al. Substance use disorders in military veterans: prevalence and treatment challenges. Subst Abuse Rehabil. 2017;8:69-77doi: 10.2147/SAR.S116720.
Teeters, J. B., Lancaster, C. L., Brown, D. G., & Back, S. E. (2017). Substance use disorders in military veterans: prevalence and treatment challenges. Substance abuse and rehabilitation, 869-77. https://doi.org/10.2147/SAR.S116720
Teeters, Jenni B, et al. "Substance use disorders in military veterans: prevalence and treatment challenges." Substance abuse and rehabilitation vol. 8 (2017): 69-77. doi: https://doi.org/10.2147/SAR.S116720
Teeters JB, Lancaster CL, Brown DG, Back SE. Substance use disorders in military veterans: prevalence and treatment challenges. Subst Abuse Rehabil. 2017 Aug 30;8:69-77. doi: 10.2147/SAR.S116720. eCollection 2017. PMID: 28919834; PMCID: PMC5587184.
Copy Download .nbib Format: NLM
Sodium-glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions.

International journal of nephrology and renovascular disease

D'Elia JA, Segal AR, Bayliss GP, Weinrauch LA.
PMID: 28670136
Int J Nephrol Renovasc Dis. 2017 Jun 15;10:153-158. doi: 10.2147/IJNRD.S135899. eCollection 2017.

OBJECTIVE: To evaluate whether adverse event reports to the US Food and Drug Administration on incidents of ketoacidosis from use of sodium glucose cotransport inhibitors (SGLT2 inhibitors) provide insight into ways this new class of drugs is being prescribed...

Cite
D'Elia JA, Segal AR, Bayliss GP, et al. Sodium-glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions. Int J Nephrol Renovasc Dis. 2017;10:153-158doi: 10.2147/IJNRD.S135899.
D'Elia, J. A., Segal, A. R., Bayliss, G. P., & Weinrauch, L. A. (2017). Sodium-glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions. International journal of nephrology and renovascular disease, 10153-158. https://doi.org/10.2147/IJNRD.S135899
D'Elia, John A, et al. "Sodium-glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions." International journal of nephrology and renovascular disease vol. 10 (2017): 153-158. doi: https://doi.org/10.2147/IJNRD.S135899
D'Elia JA, Segal AR, Bayliss GP, Weinrauch LA. Sodium-glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions. Int J Nephrol Renovasc Dis. 2017 Jun 15;10:153-158. doi: 10.2147/IJNRD.S135899. eCollection 2017. PMID: 28670136; PMCID: PMC5479258.
Copy Download .nbib Format: NLM
Certifying and measuring competency in the United States.

Archives of physical medicine and rehabilitation

DeLisa JA.
PMID: 10987169
Arch Phys Med Rehabil. 2000 Sep;81(9):1236-41. doi: 10.1053/apmr.2000.17876.

No abstract available.

Cite
DeLisa JA. Certifying and measuring competency in the United States. Arch Phys Med Rehabil. 2000;81(9):1236-41doi: 10.1053/apmr.2000.17876.
DeLisa, J. A. (2000). Certifying and measuring competency in the United States. Archives of physical medicine and rehabilitation, 81(9), 1236-41. https://doi.org/10.1053/apmr.2000.17876
DeLisa, J A. "Certifying and measuring competency in the United States." Archives of physical medicine and rehabilitation vol. 81,9 (2000): 1236-41. doi: https://doi.org/10.1053/apmr.2000.17876
DeLisa JA. Certifying and measuring competency in the United States. Arch Phys Med Rehabil. 2000 Sep;81(9):1236-41. doi: 10.1053/apmr.2000.17876. PMID: 10987169.
Copy Download .nbib Format: NLM
Peer review of clinical research applications: leveling the playing field.

The journal of spinal cord medicine

DeLisa JA.
PMID: 11944779
J Spinal Cord Med. 2001;24(4):229. doi: 10.1080/10790268.2001.11753578.

No abstract available.

Cite
DeLisa JA. Peer review of clinical research applications: leveling the playing field. J Spinal Cord Med. 2001;24(4):229doi: 10.1080/10790268.2001.11753578.
DeLisa, J. A. (2001). Peer review of clinical research applications: leveling the playing field. The journal of spinal cord medicine, 24(4), 229. https://doi.org/10.1080/10790268.2001.11753578
DeLisa, J A. "Peer review of clinical research applications: leveling the playing field." The journal of spinal cord medicine vol. 24,4 (2001): 229. doi: https://doi.org/10.1080/10790268.2001.11753578
DeLisa JA. Peer review of clinical research applications: leveling the playing field. J Spinal Cord Med. 2001;24(4):229. doi: 10.1080/10790268.2001.11753578. PMID: 11944779.
Copy Download .nbib Format: NLM
Diabetic microvascular complications: possible targets for improved macrovascular outcomes.

International journal of nephrology and renovascular disease

D'Elia JA, Bayliss G, Roshan B, Maski M, Gleason RE, Weinrauch LA.
PMID: 21694944
Int J Nephrol Renovasc Dis. 2011;4:1-15. doi: 10.2147/IJNRD.S14716. Epub 2010 Dec 22.

The results of recent outcome trials challenge hypotheses that tight control of both glycohemoglobin and blood pressure diminishes macrovascular events and survival among type 2 diabetic patients. Relevant questions exist regarding the adequacy of glycohemoglobin alone as a measure...

Cite
D'Elia JA, Bayliss G, Roshan B, et al. Diabetic microvascular complications: possible targets for improved macrovascular outcomes. Int J Nephrol Renovasc Dis. 2010;4:1-15doi: 10.2147/IJNRD.S14716.
D'Elia, J. A., Bayliss, G., Roshan, B., Maski, M., Gleason, R. E., & Weinrauch, L. A. (2011). Diabetic microvascular complications: possible targets for improved macrovascular outcomes. International journal of nephrology and renovascular disease, 41-15. https://doi.org/10.2147/IJNRD.S14716
D'Elia, John A, et al. "Diabetic microvascular complications: possible targets for improved macrovascular outcomes." International journal of nephrology and renovascular disease vol. 4 (2011): 1-15. doi: https://doi.org/10.2147/IJNRD.S14716
D'Elia JA, Bayliss G, Roshan B, Maski M, Gleason RE, Weinrauch LA. Diabetic microvascular complications: possible targets for improved macrovascular outcomes. Int J Nephrol Renovasc Dis. 2011;4:1-15. doi: 10.2147/IJNRD.S14716. Epub 2010 Dec 22. PMID: 21694944; PMCID: PMC3108788.
Copy Download .nbib Format: NLM
Commentary: More implications of the 2008 amendments to the Americans with Disabilities Act: influencing institutional policies, practices, and procedures.

Academic medicine : journal of the Association of American Medical Colleges

DeLisa J, Silverstein R, Thomas P.
PMID: 21613889
Acad Med. 2011 Jun;86(6):677-9. doi: 10.1097/ACM.0b013e318217ee74.

The Americans with Disabilities Act (ADA) is a civil rights law designed to ensure that qualified individuals with disabilities are not discriminated against by covered entities. Under the ADA, colleges of medicine were expected to focus their attention on...

Cite
DeLisa J, Silverstein R, Thomas P. Commentary: More implications of the 2008 amendments to the Americans with Disabilities Act: influencing institutional policies, practices, and procedures. Acad Med. 2011;86(6):677-9doi: 10.1097/ACM.0b013e318217ee74.
DeLisa, J., Silverstein, R., & Thomas, P. (2011). Commentary: More implications of the 2008 amendments to the Americans with Disabilities Act: influencing institutional policies, practices, and procedures. Academic medicine : journal of the Association of American Medical Colleges, 86(6), 677-9. https://doi.org/10.1097/ACM.0b013e318217ee74
DeLisa, Joel, et al. "Commentary: More implications of the 2008 amendments to the Americans with Disabilities Act: influencing institutional policies, practices, and procedures." Academic medicine : journal of the Association of American Medical Colleges vol. 86,6 (2011): 677-9. doi: https://doi.org/10.1097/ACM.0b013e318217ee74
DeLisa J, Silverstein R, Thomas P. Commentary: More implications of the 2008 amendments to the Americans with Disabilities Act: influencing institutional policies, practices, and procedures. Acad Med. 2011 Jun;86(6):677-9. doi: 10.1097/ACM.0b013e318217ee74. PMID: 21613889.
Copy Download .nbib Format: NLM
Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial.

International journal of nephrology and renovascular disease

Weinrauch LA, Claggett B, Liu J, Finn PV, Weir MR, Weiner DE, D'Elia JA.
PMID: 29760559
Int J Nephrol Renovasc Dis. 2018 Apr 27;11:155-164. doi: 10.2147/IJNRD.S161001. eCollection 2018.

BACKGROUND: Tobacco use remains an international health problem with between 10% and 40% of adults currently using tobacco. Given the rising number of patients either awaiting or having received a kidney transplant and the absence of smoking cessation as...

Cite
Weinrauch LA, Claggett B, Liu J, et al. Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial. Int J Nephrol Renovasc Dis. 2018;11:155-164doi: 10.2147/IJNRD.S161001.
Weinrauch, L. A., Claggett, B., Liu, J., Finn, P. V., Weir, M. R., Weiner, D. E., & D'Elia, J. A. (2018). Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial. International journal of nephrology and renovascular disease, 11155-164. https://doi.org/10.2147/IJNRD.S161001
Weinrauch, Larry A, et al. "Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial." International journal of nephrology and renovascular disease vol. 11 (2018): 155-164. doi: https://doi.org/10.2147/IJNRD.S161001
Weinrauch LA, Claggett B, Liu J, Finn PV, Weir MR, Weiner DE, D'Elia JA. Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial. Int J Nephrol Renovasc Dis. 2018 Apr 27;11:155-164. doi: 10.2147/IJNRD.S161001. eCollection 2018. PMID: 29760559; PMCID: PMC5937486.
Copy Download .nbib Format: NLM
Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines.

International journal of breast cancer

Winnike JH, Stewart DA, Pathmasiri WW, McRitchie SL, Sumner SJ.
PMID: 30363973
Int J Breast Cancer. 2018 Sep 30;2018:2063540. doi: 10.1155/2018/2063540. eCollection 2018.

PURPOSE: To conduct an exploratory study to identify mechanisms that differentiate Luminal A (BT474 and MCF-7) and triple-negative (MDA-MB-231 and MDA-MB-468) breast cancer (BCa) cell lines to potentially provide novel therapeutic targets based on differences in energy utilization.METHODS: Cells...

Cite
Winnike JH, Stewart DA, Pathmasiri WW, et al. Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines. Int J Breast Cancer. 2018;2018:2063540doi: 10.1155/2018/2063540.
Winnike, J. H., Stewart, D. A., Pathmasiri, W. W., McRitchie, S. L., & Sumner, S. J. (2018). Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines. International journal of breast cancer, 20182063540. https://doi.org/10.1155/2018/2063540
Winnike, Jason H, et al. "Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines." International journal of breast cancer vol. 2018 (2018): 2063540. doi: https://doi.org/10.1155/2018/2063540
Winnike JH, Stewart DA, Pathmasiri WW, McRitchie SL, Sumner SJ. Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines. Int J Breast Cancer. 2018 Sep 30;2018:2063540. doi: 10.1155/2018/2063540. eCollection 2018. PMID: 30363973; PMCID: PMC6186330.
Copy Download .nbib Format: NLM
Author Correction: Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery.

Nature communications

Jaroentomeechai T, Stark JC, Natarajan A, Glasscock CJ, Yates LE, Hsu KJ, Mrksich M, Jewett MC, DeLisa MP.
PMID: 30127449
Nat Commun. 2018 Aug 20;9(1):3396. doi: 10.1038/s41467-018-05620-8.

The original version of this Article contained an error in Figure 2, wherein the bottom right western blot panel in Figure 2a was blank. This has now been corrected in both the PDF and HTML versions of the Article.

Cite
Jaroentomeechai T, Stark JC, Natarajan A, et al. Author Correction: Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery. Nat Commun. 2018;9(1):3396doi: 10.1038/s41467-018-05620-8.
Jaroentomeechai, T., Stark, J. C., Natarajan, A., Glasscock, C. J., Yates, L. E., Hsu, K. J., Mrksich, M., Jewett, M. C., & DeLisa, M. P. (2018). Author Correction: Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery. Nature communications, 9(1), 3396. https://doi.org/10.1038/s41467-018-05620-8
Jaroentomeechai, Thapakorn, et al. "Author Correction: Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery." Nature communications vol. 9,1 (2018): 3396. doi: https://doi.org/10.1038/s41467-018-05620-8
Jaroentomeechai T, Stark JC, Natarajan A, Glasscock CJ, Yates LE, Hsu KJ, Mrksich M, Jewett MC, DeLisa MP. Author Correction: Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery. Nat Commun. 2018 Aug 20;9(1):3396. doi: 10.1038/s41467-018-05620-8. PMID: 30127449; PMCID: PMC6102295.
Copy Download .nbib Format: NLM
Proposed roadmap to stepwise integration of genetics in family medicine and clinical research.

Clinical and translational medicine

Houwink EJ, Sollie AW, Numans ME, Cornel MC.
PMID: 23415259
Clin Transl Med. 2013 Feb 16;2(1):5. doi: 10.1186/2001-1326-2-5.

We propose A step-by-step roadmap to integrate genetics in the Electronic Patient Record in Family Medicine and clinical research. This could make urgent operationalization of readily available genetic knowledge feasible in clinical research and consequently improved medical care.Improving genomic...

Cite
Houwink EJ, Sollie AW, Numans ME, et al. Proposed roadmap to stepwise integration of genetics in family medicine and clinical research. Clin Transl Med. 2013;2(1):5doi: 10.1186/2001-1326-2-5.
Houwink, E. J., Sollie, A. W., Numans, M. E., & Cornel, M. C. (2013). Proposed roadmap to stepwise integration of genetics in family medicine and clinical research. Clinical and translational medicine, 2(1), 5. https://doi.org/10.1186/2001-1326-2-5
Houwink, Elisa Jf, et al. "Proposed roadmap to stepwise integration of genetics in family medicine and clinical research." Clinical and translational medicine vol. 2,1 (2013): 5. doi: https://doi.org/10.1186/2001-1326-2-5
Houwink EJ, Sollie AW, Numans ME, Cornel MC. Proposed roadmap to stepwise integration of genetics in family medicine and clinical research. Clin Transl Med. 2013 Feb 16;2(1):5. doi: 10.1186/2001-1326-2-5. PMID: 23415259; PMCID: PMC3599402.
Copy Download .nbib Format: NLM
Engineering a new generation of carbohydrate-based vaccines.

Current opinion in chemical engineering

Weyant KB, Mills DC, DeLisa MP.
PMID: 30568873
Curr Opin Chem Eng. 2018 Mar;19:77-85. doi: 10.1016/j.coche.2017.12.009. Epub 2018 Jan 11.

Recent advances in chemical synthesis, conjugation chemistry, engineered biosynthesis, and formulation design have spawned a new generation of vaccines that incorporate carbohydrate antigens. By providing better immunity against a variety of pathogens or malignant cells and lowering the cost...

Cite
Weyant KB, Mills DC, DeLisa MP. Engineering a new generation of carbohydrate-based vaccines. Curr Opin Chem Eng. 2018;19:77-85doi: 10.1016/j.coche.2017.12.009.
Weyant, K. B., Mills, D. C., & DeLisa, M. P. (2018). Engineering a new generation of carbohydrate-based vaccines. Current opinion in chemical engineering, 1977-85. https://doi.org/10.1016/j.coche.2017.12.009
Weyant, Kevin B, et al. "Engineering a new generation of carbohydrate-based vaccines." Current opinion in chemical engineering vol. 19 (2018): 77-85. doi: https://doi.org/10.1016/j.coche.2017.12.009
Weyant KB, Mills DC, DeLisa MP. Engineering a new generation of carbohydrate-based vaccines. Curr Opin Chem Eng. 2018 Mar;19:77-85. doi: 10.1016/j.coche.2017.12.009. Epub 2018 Jan 11. PMID: 30568873; PMCID: PMC6296769.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 294 entries